product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
IL-18 BPa/IL18BP Antibody (224) [mFluor Violet 610 SE]
catalog :
NBP2-89445MFV610
quantity :
0.1 ml
price :
599 USD
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
224
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP2-89445MFV610
SKU :
NBP2-89445MFV610
product name :
IL-18 BPa/IL18BP Antibody (224) [mFluor Violet 610 SE]
sizes available :
0.1 ml
description :
The IL-18 BPa/IL18BP Antibody (224) [mFluor Violet 610 SE] from NBP2-89445MFV610 is a 6.7e-05 antibody to . This antibody reacts with human.
target :
IL-18 BPa/IL18BP
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Monoclonal
clone :
224
conjugate :
mFluor Violet 610 SE
all_available conjugate :
Alexa Fluor 488;mFluor Violet 610 SE
dilution :
ELISA
host :
Rabbit
immunogen :
This antibody was obtained from a rabbit immunized with purified, recombinant Human IL-18 BPa/IL18BP (Accession#: NP_001034748.1; Met1-Gly194).
isotype :
IgG
purity :
Protein A purified
species :
Human
gene symbol :
IL18BP
applications :
ELISA
extended description :
Recombinant Monoclonal Antibody
USD :
599 USD
product details :
Recombinant Monoclonal Antibody
alt names :
IL-18BP, IL18BPa, interleukin 18 binding protein, interleukin-18-binding protein, MC51L-53L-54L homolog gene product, tadekinig-alfa
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments
